Healthy men with no signs of prostate cancer may wish to talk to their doctors about taking a drug that could further reduce their risk for the disease, new guidelines suggest.

Patients with inflammatory polyarthritis who take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen do not appear to have an excess risk of dying from cardiovascular disease, new research shows. Inflammatory polyarthritis is a form of rheumatoid arthritis (RA) involving two or more joints.

Topiramate is safe and effective in preventing migraine in 12- to 17-year-old patients, according to a report in the journal Pediatrics.

While topiramate is FDA-approved for migraine prophylaxis in adults, the authors explain, there are no approved drugs for migraine prophylaxis in pediatric patients.

Low-dose treatment with a drug used to treat skin psoriasis seems to help reduce nail psoriasis, according to Italian researchers.

As many as 78 percent of people with psoriasis have nail psoriasis, which includes irregular pitting, salmon-colored patches on the nail bed, separation of the nail from the nail bed and reddened and often inflamed borders on the nails.

الهيئة العامة للغذاء والدواء تحث مختصي الرعاية الصحية بضرورة أخذ الحيطة عند استخدام دواء HERCEPTIN خلال فترة الحمل .

Riyadh, June 4, 2009 – The U.S. Food and Drug Administration (FDA), the American counterpart to the Saudi Food and Drug Authority (SFDA), notified healthcare professionals of the risk of serious liver injury, including liver failure and death, with the use of propylthiouracil in adult and pediatric patients.

Hoffmann-La Roche Limited (Roche), in consultation with Health Canada, the Canadian counterpart to the Saudi Food and Drug Authority (SFDA) informed health care professional of important new safety information regarding reports of pure red cell aplasia (PRCA) in patients treated with CellCept®(mycophenolate mofetil) in combination with other immunosuppressive agents. Note that the CellCept® is registered in Saudi Arabia.

U.S. Food and Drug Administration (FDA) notified healthcare professionals that it has finished its analysis of a possible risk of higher death with cefepime, an antibiotic, following publication of a study that suggested a higher rate of death in patients treated with this drug, as compared to patients treated with similar drugs.
 

Riyadh, Jun 28,2009-, Health Canada, the Canadian counterpart to the Saudi Food and Drug Authority (SFDA), informing health care professionals and consumers of recent restrictions regarding the use of the prescription drug piroxicam.

FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes. Three of the four studies suggest an increased risk for cancer associated with use of Lantus. See .